Cargando…

Incidence of End Stage Renal Disease among Type 1 Diabetes: A Nationwide Cohort Study in Taiwan

The aim of our study was to estimate the risk of end-stage renal disease (ESRD) in type 1 diabetes mellitus (T1DM) in Taiwanese people; in addition, our goal was to determine how the age, year, and sex at registration of T1DM affects the risk. Population-based cohort study. A nationwide cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wei-Hung, Li, Chung-Yi, Wang, Wei-Ming, Yang, Deng-Chi, Kuo, Te-Hui, Wang, Ming-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603135/
https://www.ncbi.nlm.nih.gov/pubmed/25526457
http://dx.doi.org/10.1097/MD.0000000000000274
_version_ 1782394871173087232
author Lin, Wei-Hung
Li, Chung-Yi
Wang, Wei-Ming
Yang, Deng-Chi
Kuo, Te-Hui
Wang, Ming-Cheng
author_facet Lin, Wei-Hung
Li, Chung-Yi
Wang, Wei-Ming
Yang, Deng-Chi
Kuo, Te-Hui
Wang, Ming-Cheng
author_sort Lin, Wei-Hung
collection PubMed
description The aim of our study was to estimate the risk of end-stage renal disease (ESRD) in type 1 diabetes mellitus (T1DM) in Taiwanese people; in addition, our goal was to determine how the age, year, and sex at registration of T1DM affects the risk. Population-based cohort study. A nationwide cohort study of 7203 Taiwanese patients with T1DM registered in 1999 to 2010 was followed up until ESRD, death, or the end of follow-up on December 31, 2010. Annual age-, sex-, and calendar year-specific incidence rates of ESRD of the general population were used to calculate the standardized incidence ratio (SIR) of ESRD in relation to T1DM. The SIR of ESRD for male and female patients with T1DM was significantly increased at 25.85 (95% CI 23.40–28.29) and 28.08 (95% 25.45–30.71), respectively; the peak was at age 15 to 29 years for both genders. The cumulative incidence of ESRD was similar in male and female patients but was significantly higher in patients ≥ 30 years old than in patients <30 years old (10.25% vs. 3.57%, P < 0.001). Patients aged <15 years had a significantly lower risk of ESRD as compared to those aged 15 to 29 years; patients aged 30 to 44 (adjusted HR, 1.491) and 45 to 60 years (adjusted HR, 2.111) showed significantly increased hazards. Our data also demonstrated a lower risk of ESRD in patients who were registered in later years than in earlier years. The risk of ESRD is substantially increased in T1DM in the ethnic Chinese population. The continuously declining risk of ESRD in T1DM may advocate the use of a multidisciplinary chronic kidney disease care system in Taiwan.
format Online
Article
Text
id pubmed-4603135
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-46031352015-10-27 Incidence of End Stage Renal Disease among Type 1 Diabetes: A Nationwide Cohort Study in Taiwan Lin, Wei-Hung Li, Chung-Yi Wang, Wei-Ming Yang, Deng-Chi Kuo, Te-Hui Wang, Ming-Cheng Medicine (Baltimore) 4400 The aim of our study was to estimate the risk of end-stage renal disease (ESRD) in type 1 diabetes mellitus (T1DM) in Taiwanese people; in addition, our goal was to determine how the age, year, and sex at registration of T1DM affects the risk. Population-based cohort study. A nationwide cohort study of 7203 Taiwanese patients with T1DM registered in 1999 to 2010 was followed up until ESRD, death, or the end of follow-up on December 31, 2010. Annual age-, sex-, and calendar year-specific incidence rates of ESRD of the general population were used to calculate the standardized incidence ratio (SIR) of ESRD in relation to T1DM. The SIR of ESRD for male and female patients with T1DM was significantly increased at 25.85 (95% CI 23.40–28.29) and 28.08 (95% 25.45–30.71), respectively; the peak was at age 15 to 29 years for both genders. The cumulative incidence of ESRD was similar in male and female patients but was significantly higher in patients ≥ 30 years old than in patients <30 years old (10.25% vs. 3.57%, P < 0.001). Patients aged <15 years had a significantly lower risk of ESRD as compared to those aged 15 to 29 years; patients aged 30 to 44 (adjusted HR, 1.491) and 45 to 60 years (adjusted HR, 2.111) showed significantly increased hazards. Our data also demonstrated a lower risk of ESRD in patients who were registered in later years than in earlier years. The risk of ESRD is substantially increased in T1DM in the ethnic Chinese population. The continuously declining risk of ESRD in T1DM may advocate the use of a multidisciplinary chronic kidney disease care system in Taiwan. Wolters Kluwer Health 2014-12-02 /pmc/articles/PMC4603135/ /pubmed/25526457 http://dx.doi.org/10.1097/MD.0000000000000274 Text en © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4400
Lin, Wei-Hung
Li, Chung-Yi
Wang, Wei-Ming
Yang, Deng-Chi
Kuo, Te-Hui
Wang, Ming-Cheng
Incidence of End Stage Renal Disease among Type 1 Diabetes: A Nationwide Cohort Study in Taiwan
title Incidence of End Stage Renal Disease among Type 1 Diabetes: A Nationwide Cohort Study in Taiwan
title_full Incidence of End Stage Renal Disease among Type 1 Diabetes: A Nationwide Cohort Study in Taiwan
title_fullStr Incidence of End Stage Renal Disease among Type 1 Diabetes: A Nationwide Cohort Study in Taiwan
title_full_unstemmed Incidence of End Stage Renal Disease among Type 1 Diabetes: A Nationwide Cohort Study in Taiwan
title_short Incidence of End Stage Renal Disease among Type 1 Diabetes: A Nationwide Cohort Study in Taiwan
title_sort incidence of end stage renal disease among type 1 diabetes: a nationwide cohort study in taiwan
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603135/
https://www.ncbi.nlm.nih.gov/pubmed/25526457
http://dx.doi.org/10.1097/MD.0000000000000274
work_keys_str_mv AT linweihung incidenceofendstagerenaldiseaseamongtype1diabetesanationwidecohortstudyintaiwan
AT lichungyi incidenceofendstagerenaldiseaseamongtype1diabetesanationwidecohortstudyintaiwan
AT wangweiming incidenceofendstagerenaldiseaseamongtype1diabetesanationwidecohortstudyintaiwan
AT yangdengchi incidenceofendstagerenaldiseaseamongtype1diabetesanationwidecohortstudyintaiwan
AT kuotehui incidenceofendstagerenaldiseaseamongtype1diabetesanationwidecohortstudyintaiwan
AT wangmingcheng incidenceofendstagerenaldiseaseamongtype1diabetesanationwidecohortstudyintaiwan